エンドトキシン研究7　―可能性を求めて―

出版社： 医学図書出版
著者：
発行日： 2004-11-15
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 4871513270
電子書籍版： 2004-11-15 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,400 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

商品紹介

全敗血症患者の約40%がグラム陰性菌による感染症であり、これら患者の約半数が菌血症である。敗血症性ショックに至る可能性が高いグラム陰性菌血症の病態解明に、本書において、基礎から臨床まで幅広い分野からの研究を網羅した。

目次

  • エンドトキシン研究7　―可能性を求めて―

    ―目次―

    第１章　特別講演
    第２章　構造と活性
    第３章　受容体と反応
    第４章　各種治療の作用機序
    第５章　測定法の検討

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.10 掲載の参考文献
1) Madden KS, Felten DL : Experimental basis for neural-immune interactions. Physiol Rev 75 : 77-106, 1995
PubMed
2) Madden KS, Sanders VM, Felten DL : Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35 : 417-448, 1995
PubMed
3) Leo NA, Callahan TA, Bonneau RH : Peripheral sympathetic denervation alters both the primary and memory cellular immune responses to herpes simplex virus infection. Neuroimmunomodulation 5 : 22-35, 1998
PubMed
4) Madden KS, Felten SY, Felten DL, et al. : Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy. Brain Behav Immun 3 : 72-89, 1989
PubMed
5) Kruszewska B, Felte SY, Moynihan JA : Alteration in cytokine and antibody production following chemical sympathectomy in two different strains of mice. J Immunol 155 : 4613-4620, 1995
 
6) Chelmicka-Schorr E, Checinski M, Arnason BGW : Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J Neuroimmunol 17 : 347-350, 1988
 
7) Felten DL, Felten SY, Bellinger DL, et al. : Noradrenergic and peptidergic innervation of secondary lymphoid organs : role in experimental rheumatoid arthritis. Eur J Clin Invest 22 : 37-41, 1992
PubMed
8) De Luigi A, Terreni L, Sironi M, et al. : The sympathetic nervous system tonically inhibits peripheral interleukin-1β and interleukin-6 by central lipopolysaccharide. Neuroscience 83 : 1245-1250, 1998
 
9) Hatfield SM, Petersen BH, Dimicco JA : Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro. J Pharmacol Exp Ther 239 : 460-466, 1986
PubMed
10) Sanders VM, Munson AE : Beta-adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J pharmacol Exp Ther 230 : 183-192, 1984
PubMed
11) Chelmicka-Schorr E, Kwasniewski MN, Thomas BE, et al. : The β-adrenergic agonist isoproterenol supPresses experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 25 : 203-207, 1989
 
12) Schedlowski M, Hosch W, Oberbeck R, et al. : Catecholamines modulate human NK cell circulation and function via spleen-independent β2-adrenergic mechanisms. J Immunol 156 : 93-99, 1996
 
13) Altenburg SP, Martins MA, Silva AR, et al. : LPS-induced blood neutrophilia is inhibited by α1-adrenoceptor antagonists : a role for catecholamines. J Leukoc Biol 61 : 689-694, 1997
 
14) Altenburg WC, Dunegan MA : Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol 135 : 350-354, 1985
 
15) van der Poll T, Jansen J, Endert E, et al. : Noradrenaline inhibits lipoplysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62 : 2046-2050, 1994
 
16) Cole SW, Korin YD, Fahey J, et al. : Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 161 : 610-616, 1998
PubMed
17) Sanders VM, Baker RA, Ramer-Quinn DS, et al. : Differential expression of the β2-adrenergic receptor by Th1 and Th 2 clones. Implication for cytokine production and B cell help. J Immunol 158 : 4200-4210, 1997
 
18) Ramer-Quinn DS, Baker RA, Sanders VM : Activated T helper 1 and T helper 2 cells differentially express the β2-adrenergic receptor. A mechanism for selective modulation of Thelper 1 cell cytokine production. J Immunol 159 : 4857-4867, 1997
 
19) Panina-Bordignon P, Mazzeo D, Di Lucia P, et al. : β2-agonists prevent Th 1 development by selective inhibition of interleukin 12. J Clin Invest 100 : 1513-1519, 1997
 
20) Miura T, Kudo T, Matsuki A, et al. : Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection. Infect Immun 69 : 7234-7241, 2001
PubMed
21) Suzuki S, Toyabe S, Moroda T, et al. : Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 110 : 500-508, 1997
PubMed
22) Zhang Y, Proenca R, Maffei M, et al. : Positional cloning of the mouse obese gene and its human homologue. Nature 372 : 425-432, 1994
PubMed
23) Halaas JL, Gajiwala KS, Maffei M, et al. : Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 : 543-546, 1995
PubMed
24) Pelleymounter MA, Cullen MJ, Baker MB, et al. : Effects of the obese gene product on body weight regulation in ob/06 mice. Science 269 : 540-543, 1995
 
25) Campfield LA, Smith FJ, Guisez Y, et al. : Recombinant mouse OB protein : evidence for aperipheral signal linking adiposity and central neural networks. Science 269 : 546-549, 1995
 
26) Fan W, Boston BA, Kesterson RA, et al. : Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 : 165-168, 1997
PubMed
27) Tartaglia LA, Dembski M, Weng X, et al. : Identification and expression cloning of a leptin receptor, OB-R. Cell 83 : 1263-1271, 1995
PubMed
28) Masuzaki H, Ogawa Y, Aizawa-Abe M, et al. : Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation : usefulness of leptin for the treatment of obesityassociated diabetes. Diabetes 48 : 1615-1622, 1999
PubMed
29) Shimomura I, Hammer RE, Ikemoto S, et al. : Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401 : 73-76, 1999
PubMed
30) Lord GM, Matarese G, Howard JK, et al. : Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 : 897-901, 1998
 
31) Faggioni R, Jones-Carson J, Reed DA, et al. : Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity ; role of tumor necrosis factorαand IL-18. Proc Natl acad Sci USA 97 : 2367-2372, 2000
 
32) Matarese G, Di Giacomo A, Sanna V, et al. : Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166 : 5909-5916, 2001
PubMed
33) Busso N, So A, Chobaz-Peclat V, et al. : Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168 : 875-882, 2002
PubMed
34) Siegmund B, Lehr HA, Fantuzzi G : Leptin ; a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122 : 2011-2025, 2002
PubMed
35) Mancuso P, Gottschalk A, Phare SM, et al. : Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 168 : 4018-4024, 2002
PubMed
36) Moore SI, Huffnagle GB, Chen G-H, et al. : Leptin modulates neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun 71 : 4182-4185, 2003
PubMed
37) Kurihara T, Warr G, Loy J, et al. : Defects in macrophage recruitment and host defense in mice lacking the CCR 2 chemokine receptor. J Exp Med 186 : 1757-1762, 1997
 
38) Czuprynski CJ, Brown JF, Steinberg H, et al. : Mice lacking the murine interleukin-8 receptor homologue demonstrate paradoxical responses to acute and chronic experimental infection with Listeria monocytogenes. Microb Pathog 24 : 17-23, 1998
PubMed
P.22 掲載の参考文献
1) J M Dixon, C P Armstrong, S W Duffy, et al. : Factors affecting morbidity and mortality after surgery for obstructive jaundice : a review of 373 patients. Gut 24 : 845-852, 1983
 
2) J D Greig, Z H Krukowski, N A Matheson : Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 75 : 216-219, 1988
 
3) A N Kimmings, S J van Deventer, H Obertop, et al. : Inflammatory and immunologic effects of obstructive jaundice : pathogenesis and treatment. J Am Coll Surg 181 : 567-581, 1995
 
4) W R Caly, E Strauss : A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 18 : 353-358, 1993
 
5) R D Bapat, A N Supe, A Patwardhan, et al. : Biliary sepsis : an ascending infection. Indian J Gastroenterol 15 : 126-128, 1996
 
6) R Rerknimitr, E L Fogel, C Kalayci, et al. : Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 56 : 885-889, 2002
PubMed
7) J W Ding, R Andersson, V Soltesz, et al. : The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. Eur Surg Res 25 : 11-19, 1993
 
8) E A Deitch, K Sittig, M Li, et al. : Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 159 : 79-84, 1990
 
9) J V Reynolds, P Murchan, H P Redmond, et al. : Failure of macrophage activation in experimental obstructive jaundice : association with bacterial translocation. Br J Surg 82 : 534-538, 1995
 
10) S Seki, W Hashimoto, K Ogasawara, et al. : Antimetastatic effect of NK 1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice. Immunology 92 : 561-566, 1997
 
11) S Seki, S Osada, S Ono, et al. : Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice. Infect Immun 66 : 5286-5294, 1998
 
12) G Zhang, R D Nichols, M Taniguchi, et al. : Gamma interferon production by hepatic NK T cells during Escherichia coli infection is resistant to the inhibitory effects of oxidative stress. Infect Immun 71 : 2468-2477, 2003
 
13) P A Knolle, G Gerken : Local control of the immune response in the liver. Immunol Rev 174 : 21-34, 2000
 
14) J W Ding, R Andersson, L Norgren, et al. : The influence of biliary obstruction and sepsis on reticuloendothelial function in rats. Eur J Surg 158 : 157-164, 1992
 
15) K Ami, M Kinoshita, A Yamauchi, et al. : IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-18. J Immunol 169 : 4437-4442, 2002
 
16) I Miler, P Sima, V Vetvicka, et al. : The potential immunosuppressive effect of bilirubin. Allerg Immunol (Leipz) 34 : 177-184, 1988
 
17) Y Haga, M A Tempero, D Kay, et al. : Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes. Dig Dis Sci 41 : 1468-1474, 1996
 
18) I Issemann, S Green : Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 : 645-650, 1990
 
19) I Issemann, S Green : Cloning of novel members of the steroid hormone receptor superfamily. J Steroid Biochem Mol Biol 40 : 263-269, 1991
 
20) D W Russell : Nuclear orphan receptors control cholesterol catabolism. Cell 97 : 539-542, 1999
 
21) G A Francis, E Fayard, F Picard, et al. : Nuclear receptors and the control of metabolism. Annu Rev Physiol 65 : 261-311, 2003
 
22) D W Russell : The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72 : 137-174, 2003
 
23) A F Valledor, M Ricote : Nuclear receptor signaling in macrophages. Biochem Pharmacol 67 : 201-212, 2004
 
24) A Winoto, D R Littman : Nuclear hormone receptors in T lymphocytes. Cell 109 Suppl : S57-66, 2002
 
25) D J Parks, S G Blanchard, R K Bledsoe, et al. : Bile acids : natural ligands for an orphan nuclear receptor. Science 284 : 1365-1368, 1999
 
26) M Makishima, A Y Okamoto, J J Repa, et al. : Identification of a nuclear receptor for bile acids. Science 284 : 1362-1365, 1999
 
27) H Wang, J Chen, K Hollister, et al. : Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3 : 543-553, 1999
 
28) MMakishima, T T Lu, W Xie, et al. : Vitamin D receptor as an intestinal bile acid sensor. Science 296 : 1313-1316, 2002
 
29) C Song, R A Hiipakka, S Liao : Selective activation of liver X receptor alpha by 6 alpha-hydroxy bile acids and analogs. Steroids 65 : 423-427, 2000
 
30) W Xie, A Radominska-Pandya, Y Shi, et al. : An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98 : 3375-3380, 2001
 
31) J L Staudinger, B Goodwin, S A Jones, et al. : The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98 : 3369-3374, 2001
 
32) S A Kliewer, T M Willson : Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 43 : 359-364, 2002
 
33) C J Sinal, M Yoon, F J Gonzalez : Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids. J Biol Chem 276 : 47154-47162, 2001
 
34) D M Small, R H Dowling, R N Redinger : The enterohepatic circulation of bile salts. Arch Intern Med 130 : 552-573, 1972
 
35) A Chawla, E Saez, R M Evans : "Don't know much bile-ology". Cell 103 : 1-4, 2000
 
P.30 掲載の参考文献
1) Narumiya S, Ishizaki T, Uehata M. Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol 325 : 273-284, 2000
PubMed
2) Uehata M, Ishizaki T, Satoh H, et al. : Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 : 990-994, 1997
PubMed
3) Uhlmann S, Uhlmann D, Spiegel HU. Evaluation of hepatic microcirculation by in vivo microscopy. J Invest Surg 12 : 179-193, 1999
PubMed
4) Menger MD, Marzi I, Messmer K. In vivo fluorescence microscopy for quantitative analysis of the hepatic microcirculation in hamsters and rats. Eur Surg Res 23 : 158-169, 1991
PubMed
5) Kondo T, Okamoto S, Todoroki T, et al. : Application of a novel method for subsequent evaluation of sinusoids and postsinusoidal venules after ischemia-reperfusion injury of rat liver. Eur Surg Res 30 : 252-258, 1998
PubMed
6) Ikeda F, Terajima H, Shimahara Y, et al. : Reduction of hepatic ischemia/reperfusioninduced injury by a specific ROCK/Rho Kinase Inhibitor Y-27632. J Surg Res 109 : 155-160, 2003
 
7) Vollmar B, Glasz J, Senkel A, et al. : Role of leukocytes in the initial hepatic microvascular response to endotoxemia. Zentralbl Chir 118 : 691-696, 1993
PubMed
8) Secchi A, Ortanderl JM, Schmidt W, et al. : Effects of dobutamine and dopexamine on hepatic micro-and macrocirculation during experimental endotoxemia : an intravital microscopic study in the rat. Crit Care Med 29 : 597-600, 2001
PubMed
9) Kanazawa A, Tanaka A, Iwata S, et al. : The beneficial effect of phosphocreatine accumulation in the creatine kinase transgenic mouse liver in endotoxin-induced hepatic cell death. JSurg Res 80 : 229-235, 1998
PubMed
10) Oda M, Han JY, Yokomori H. : Local regulators of hepatic sinusoidal microcirculation : recent advances. Clin Hemorheol Microcirc 23 : 85-94, 2000
PubMed
11) Kawada N, Seki S, Kuroki T, et al. : ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. Biochem Biophys Res Commun 266 : 296-300, 1999
PubMed
12) Granger DN, Kubes P. : The microcirculation and infiammation : modulation of leukocyteendothelial cell adhesion. J Leukoc Biol 55 : 662-675, 1994
 
13) Anderson SI, Hotchin NA, Nash GB. : Role of the cytoskeleton in rapid activation of CD 11b/CD 18 function and its subsequent downregulation in neutrophils. J Cell Sci 113 : 2737-2745, 2000
 
14) Kawaguchi A, Ohmori M, Harada K, et al. : The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes. Eur J Pharmacol 403 : 203-208, 2000
PubMed
P.35 掲載の参考文献
1) Seyama Y, Kubota K, Sano K, et al. : Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238 : 73-83, 2003
PubMed
2) Nagino M, Kamiya J, Uesaka K, et al. : Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 25 : 1277-1283, 2001
PubMed
3) Mochida S, Ogata I, Hirata K, et al. : Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 99 : 771-777, 1990
PubMed
4) Suzuki S, Nakamura S, Serizawa A, et al. : Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. Hepatology 24 : 219-225, 1996
PubMed
5) Rai RM, Loffreda S, Karp CL, et al. : Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained over expression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology 25 : 889-895, 1997
 
6) Kurachi K, Suzuki S, Sakaguchi T, et al. : Kupffer cells modulate splenic interleukin-10 production in endotoxin-induced liver injury after partial hepatectomy. J Hepatol 38 : 193-199, 2003
PubMed
7) Sakaguchi T, Nakamura S, Suzuki S, et al. : Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats. Hepatology 30 : 959-967, 1999
PubMed
8) Medzhitov R, Preston-Hurlburt P, Janeway C A Jr. : Ahuman homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 : 394-397, 1997
 
9) Janeway CA Jr, Medzhitov R. : Innate immune recognition. Annu Rev Immunol. 20 : 197-216, 2002
PubMed
10) Wright SD, Ramos RA, Tobias PS, et al. : CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249 : 1431-1433, 1990
 
11) Miyake K. : Innate recognition of lipopolysaccharide by CD 14 and tolHike receptor 4-MD-2 : unique roles for MD-2. Int Immunopharmacol. 3 : 119-128, 2003
 
12) Nagai Y, Akashi S, Nagafuku M, et al. : Essential role of MD-2 in LPS responsiveness and TLR 4 distribution. Nat Immunol. 3 : 667-672, 2002
 
13) Medvedev AE, Kopydlowski KM, Vogel SN. : Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages : dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol. 164 : 5564-5574, 2000
PubMed
14) Higgins GM, Anderson RM. : Experimental pathology of the liver. Arch Pathol 12 : 186-202, 1931
 
15) Poltorak A, He X, Smirnova I, et al. : Defective LPS signaling in C 3 H/HeJ and C 57 BL/10 ScCr mice : mutations in Tlr 4 gene. Science. 282 : 2085-2088, 1998
 
16) Qureshi ST, Lariviere L, Leveque G, et al. : Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr 4) . J. Exp. Med. 189 : 615-625, 1999
 
P.45 掲載の参考文献
1) Hotchkiss RS. , Karl IE. : The pathophysiology and treatment of sepsis. N Eng J Med 348 : 138-150, 2003
 
2) 高野祐久, 吉川敏一, 近藤元治 : フリーラジカル : 一酸化窒素 (NO) . "ショック1995-1996", 玉熊正悦編. 中山書店, 1995, p34-39
 
3) 丁宗鉄鐡 : 小柴胡湯 (1) . 漢方医学 120 : 159-165, 1996
 
4) Yano H, Mizoguchi A, Fukuda K. et al. : The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the Go/Gl phase. Cancer Res 54 : 448-454, 1994
 
5) 岡博, 織田敏次 : 慢性肝炎とBRMとしての漢方薬. "最新の漢方薬理" 細谷英吉, 山村雄一監修, Excerpta Medica, 1988, p. 355-362
 
6) Sakaguchi S, Tsutsmi E, Yokota K, et al. : Preventive effects of a Chinese herb medicine (Sho-saiko-to) against lethality after recombinant human tumor necrosis factor administration in mice. Microbiol Immunol 35 : 389-394, 1991
 
7) Sakaguchi S, Tsutsumi E, Yokota K : Preventive effects of a traditional Chinese medicine (Sho-saiko-to) against oxygen toxicity and membrane damage during endotoxemia. Biol Pharm Bull 16 : 782-786, 1993
PubMed
8) Sakaguchi S, Tsutsumi E, Yokota K : Defense effects of a traditional Chinese medicine (Sho-saiko-to) against metabolic disorders during endotoxemia ; approached from the behavior of the calcium ion. Biol Pharm Bull 17 : 232-236, 1994
PubMed
9) Sakaguhi S, Furusawa S, Yokota K, et al. : Depressive effect of a traditional Chinese medicine (Sho-saiko-to) on endotoxin-induced nitric oxide formation in activated murine macrophage J 774 A. 1 cell. Biol Pharm Bull 18 : 621-623, 1995
 
10) Sakaguchi S, Furusawa S, Yokota K, et al. : Effects of antitumor activity and protection of shock symptoms by a traditional Chinese medicine (Sho-saiko-to) in recombinant human tumor necrosis factor administered mice. Biol Pharm Bull 19 : 1474-1478, 1996
 
11) Lehmann V, Freudenberg MA, Galanos C : Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and Dgalactosamine-treated mice. J Exp Med 165 : 657-663, 1987
PubMed
12) 前田利夫 : 小柴胡湯のグルココルチコイド増強作用-TAT誘導作用について-. 漢方医学 11 : 24-27, 1987
 
13) Kubo M, Matsuda H, Tani T, et al. : Studies on scutellariae radix. XII. Anti-thrombic actions of various flavonoids from scutellariae radix. Chem Pharm Bull 33 : 2411-2415, 1985
PubMed
14) Kimura Y Kubo M Tani T et al. : Studies on scutellariae radix IV. Effects on lipid peroxidation in rat liver. Chem Pharm Bull 29 : 2610-2617, 1981
 
15) 宮原正信, 巽義男 : 小柴胡湯及びその成分による脂質過酸化反応抑制. 薬学雑誌 110 : 407-413, 1990
 
16) Titheradge MA : Nitric oxide in septic shock. Biochim Biophys Acta 1411 : 437-455, 1999
PubMed
17) Cheung JY, Bonventer JV, Malis CO, et al. : Calcium and ischemic inj ury. N Engl J Med 314 : 1670-1676, 1986
 
18) Sakaguchi S, Tsutsumi E, Yokota K : Decline plasma membrane Ca2+ -ATPase and increase in cytosolic-free Ca2+ concentratrion of endotoxin-injected mice. Biol Pharm Bull 16 : 808-810, 1993
 
19) Kaneko M, Beamish RE, Dhalla NS : Depression of hearsarcolemmal Ca2+-pump activity by oxygen free radicals. Am J physiol 256 : H368-H374, 1989
PubMed
20) Sakaguchi S, Kanda N, Hsu CC, et al. : Lipid peroxide formation and membrane damage in endotoxin-poisoned mice. Microbiol Immunol 25 : 229-244, 1981
PubMed
21) 高橋和弘, 柴原茂樹 : 酸化ストレス, NOとヘムオキシゲナーゼ-1. 医学のあゆみ 188 : 1121-1124, 1999
 
22) Poss KD, Tonegawa S : Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94 : 10919-10924, 1997
PubMed
23) Sakaguchi S, Iizuka Y, Furusawa S, et al. : Haem metabolic aspects on nitric oxide formation in endotoxemia. Pharmacol Toxicol 89 : 273-276, 2001
PubMed
24) Minamiyama Y, Takemura S, Imaoka S : Irreversible inhibition of cytochrome P 450 by nitric oxide. J pharmacol Exp Ther 283 : 1479-1485, 1997
PubMed
25) Takahashi K, Hara E, Ogawa K, et al. : Possible implications of the induction of human heme oxygenase-1 by nitric oxide donors. J Biochem (Tokyo) 121 : 1162-1168, 1997
PubMed
P.53 掲載の参考文献
1) Schultz CP, Wolf V, Lange R, et al. : Evidence for a new type of outer membrane lipid in oral spirochete TrOPonema den tico la. Functioning permeation barrier without lipopolysaccharides. J Biol Chem 273 : 15661-15666, 1998
 
2) Schroder NW, Opitz B, Lamping N, et al. : Involvement of lipopolysaccharide binding protein, CD 14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J Immunol 165 : 2683-2693, 2000
 
3) SchrOder NW, Pfeil D, Opitz B, et al. : Activation of mitogen-activated protein kinases P42/44, P38, and stress-activated protein kinases in myelo-monocytic cells by Treponema lipoteichoic acid. J Biol Chem 276 : 9713-9719, 2001
PubMed
4) Opitz B, Schr6der NW, Spreitzer I, et al. : Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-x Btranslocation. J Biol Chem 276 : 22041-22047, 2001
 
5) Hashimoto M, Asai Y, Jinno T, et al. : Structural elucidation of polysaccharide part of glycoconjugate freponema medium ATCC 700293. Eur J Biochem 270 : 2671-2679, 2003
PubMed
6) Shashkov AS, Lipkind GM, Knirel YA, et al. : Stereochemical factors determining the effects of glycosylation on the 13 C chemical shifts in carbohydrates. Magn Reson Chem 26 : 735-747, 1988
 
7) Perepelov AV, Senchenkova AN, Shashkov AS, et al. : First application of triflic acid for selective cleavage of glycosidic linkages in structural studies of a bacterial polysaccharide from Pseudoalteromonas sp. KMM 634. J Chem Soc, Perkin Trans 1 : 363-366, 2000
 
8) Aderem A, Ulevitch RJ : Toll-like receptors in the induction of the innate immune response. Nature 406 : 782-787, 2000
PubMed
9) Schumann RR, Latz E : Lipopolysaccharidebinding protein. Chem Immunol 74 : 42-60, 2000
PubMed
10) Asai Y, Hashimoto M, Ogawa T : Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD 14 functions. Eur J Immunol 33 : 3196-3204, 2003
 
11) Hashimoto M, Asai Y, Ogawa T : Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J Biol Chem 278 : 44205-44213, 2003
PubMed
P.63 掲載の参考文献
1) Cohen J : The immunopathogenesis of sepsis. Nature 420 : 885-891, 2002
PubMed
2) Hancock R E W, Diamond G : The role of cationic antimicrobial peptides in innate host defences. Trends Micobiol 8 : 402-410, 2000
 
3) Gennaro R, Zanetti M : Structural features and biological activities of the cathelicidinderived antimicrobial peptides. Biopolymers 55 : 31-49, 2000
PubMed
4) Ramanathan B, Davis E G, Ross C R, et al. : Cathelicidins : microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect 4 : 361-372, 2002
PubMed
5) Yomogida S, Nagaoka I, Yamashita T : Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch Biochem Biopys 328 : 219-226, 1996
 
6) Nagaoka I, Tsutsumi-Ishii Y, Yomogida S, et al. : Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptides of 11kDa (CAP 11) and evaluation of CAP 11 mRNA expression during neutrophil maturation. J Biol Chem 272 : 22742-22750, 1997
 
7) Nagaoka I, Hirota S, Yomogida S, et al. : Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res 49 : 73-79, 2000
PubMed
8) Nagaoka I, Hirota S, Niyonsaba F, et al. : Cathelicidin family of antibacterial peptides CAP 18 and CAP 11 inhibit the expression of TNF-α by blocking the binding of LPS to CD 14+ cells. J Immunol 167 : 3329-3338, 2001
 
9) Majewska E, Sulowska Z, Baj Z : Spontaneous apoptosis of neutrophils in whole blood and its relation to apoptosis gene proteins. Scand J Immunol 52 : 496-501, 2000
PubMed
10) Vermes I, Haanen C, Reutelingsperger C : Flow cytometry of apoptotic cell death. J Immunol Methods 243 : 167-190, 2000
PubMed
11) Akgul C, Moulding D A, Edwards S W : Molecular control of neutrophil apoptosis. FEBS Lett 487 : 318-322, 2001
PubMed
12) Weinmann P, Gaehtgens P, Walzog B : Bcl-X1- and Bax-α-mediated regulation of apoptosis of human neutrophils via caspase-3. Blood 93 : 3106-3115, 1999
 
13) Perera P Y, Mayadas T N, Takeuchi O, et al. : CD llb/CD 18 acts in concert with CD 14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166 : 574-581, 2002
 
14) Kaisho T, Akira S : Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589 : 1-13, 2002
PubMed
15) Triantafilou, M, Triantafilou K : Lipopolysaccharide recognition : CD 14, TLRs and the LPS-activation cluster. Trends Immunol 23 : 301-304, 2002
 
16) Colotta F, Re F, Polentarutti N, et al. : Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80 : 2012-2020, 1992
PubMed
17) Leuenroth S, Lee C, Grutkoski P, et al. : Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD 95 (Fas/Apo-1) Fas-1 interactions. Surgery 124 : 409-417, 1998
 
18) Lehrer R I, Lichtenstein A K, Ganz T : Defensins : antimicrobial and cytotoxic peptides of mammalian cells. Ann Rev Immunol 11 : 105-128, 1993
 
19) Hancock R E W, Scott M G : The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97 : 8856-8861. 2000
 
20) Larrick J W, Hirata M, Shimomura Y, et al. : Antimicrobial activity of rabbit CAP 18-derived peptides. Antimicrob Agents Chemother 37 : 2534-2539, 1993
 
21) Hirata M, Shimomura Y, Yoshida M, et al. : Characterization of a rabbit cationic protein (CAP 18) with lipopolysaccharide-inhibitory activity. Infect Immun 62 : 1421-1426, 1994
PubMed
22) Ward C, Dransfield I, Chilvers E R, et al. : Pharmacological manipulation of granulocyte apoptosis : potential therapeutic targets. Trends Pharmacol Sci 20 : 503-509, 1999
PubMed
23) 0berholzer C, Oberholzer A, Clare-Salzler M, et al. : Apoptosis in sepsis : anew target for therapeutic exploration. FASEB J 15 : 879-892, 2001
 
24) Riedemann N C, Guo R F, Ward P A : Novel strategies for the treatment of sepsis. Nat Med 9 : 517-524, 2003
PubMed
25) Pyatt D W, Stillman W S, Yang Y, et al. : An essential role for NF-κB in human CD34+ bone marrow cell survival. J Immunol 93 : 3302-3308, 1999
 
P.71 掲載の参考文献
1) Rustici A, Velucchi M, Faggioni R, et al. : Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 15259 : 361-365, 1993
 
2) Iwanaga S, Kawabata S, Muta T : New Types of Clotting factors and Defence Molecules Found in Horseshoe Crab Hemolymph : Their Structure and Fuctions. J Biochem 123 : 1-15, 1998
 
3) Capodici C, Weiss J : Both N-and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing Protein are required for stability and function. J. Immunology 156 : 4789-4796, 1996
 
4) Hirata M, Shimomura Y, Yoshida M, et al. : Characterization of rabbit cationic protein (CAP 18) with lipopolysaccharide-inhibitory activity. Infect Immun 62 : 1421-1426, 1994
PubMed
5) Larrick J W, Hirata M, Zhong J, et al. : Anti-microbial activity of human CAP 18 peptides. Immunotechnology 1 : 65-72, 1995
 
6) Reyes O, Vallespi MG, Garay HE, et al. : Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library. J Pept Sci 8 : 144-150, 2002
PubMed
7) Wilde CG, Seilhamer JJ, McGrogan M, et al. : Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS) -binding protein. LPS binding properties and effects on LPS-mediated cell activation. J Biol Chem 269 : 17411-17416, 1994
PubMed
8) Frey EA, Miller DS, Jahr TG, et al. : Soluble CD 14 participate in the response of cells lipopolysaccharide. J Exp Med 176 : 1665-1671, 1992
 
9) Juan TS, Hailman E, Kelley MJ, et al. : Identification of a Iipopolysaccharide binding domain in CD 14 between amino acids 57 and 64. J Biol Chem 10270 : 5219-5224, 1995
 
10) Elass-Rochard E, Legrand D, Salmon V, et al. : Lactoferrin inhibits the endotoxin interaction with CD 14 by competition with the lipopolysaccharide-binding Protein. Infect Immun 66 : 486-491, 1998
 
11) Kaca W, Roth RI, Levin J. : Hemoglobin, a newly recognized lipopolysaccharide (LPS) -binding protein that enhances LPS biological activity. J Biol Chem 7 269 : 25078-25084, 1994
 
12) Liepke C, Baxmann S, Heine C, et al. : Human hemoglobin-derived peptides exhibit antimicrobial activity : a class of host defense peptides. J Chromatogr B Analyt Technol Biomed Life Sci. 5791 : 345-356, 2003
 
13) Dankesreiter S, Hoess A, Schneider-Mergener J, et al. : Synthetic endotosxin-binding Peptides block endotoxin-triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. Jimmunology 164 : 4804-4811, 2000
 
14) Hirata M, Zhong J, Wright SC, et al. : Structure and functions of endotoxin-binding Peptides derived from CAP 18. Prog Clin Biol Res 392 : 317-326, 1995
PubMed
15) Turner J, Cho Y, Dinh NN, et al. : Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42 : 2206-2214, 1998
PubMed
16) Schumann RR, Lamping N, Hoess A : Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. J Immunology 159 : 5599-5605, 1997
 
17) Muhle SA, Tam Jp : Design of gram-negative selective antimicrobial peptides. Biochemistry 40 : 5777-5785, 2001
PubMed
18) Smith GP : Filamentous fusion phage : novel expression vectors that display cloned antigens on the virion surface. Science 14 228 : 1315-1317, 1985
 
19) Noda K, Yamasaki R, Hirooka Y, et al. : Selection of R-form lipopolysaccharide from aphage displayed heptapeptide library. FEMS Microbiol Lett 205 : 349-354, 2000
 
20) Yong Zhu, Bow Ho, Jeak Ling Ding : Sequence and structural diversity in endotoxin-binding dodecapeptides. Biochimica et Biophysica Acta-Biomembranes 1611 : 234-242, 2003
 
21) Hotchkiss RS, Karl IE : The pathophysiology and treatment of sepsis. N Engl J Med 9 348 : 138-150, 2003
 
P.83 掲載の参考文献
1) Ross GD, Cain JA, Myones BL, et al. : Specificity of membrane complement receptor type three (CR 3) for β-glucans. Complement 4 : 61-74, 1987
 
2) Brown GD, Gordon S : Immune recognition. A new receptor for β-glucans. Nature 413 : 36-37, 2001
 
3) Gantner BN, Simmons RM, Canavera SJ, et al. : Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197 : 1107-1117, 2003
PubMed
4) Ariizumi K, Shen GL, Shikano S, et al. : Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 275 : 20157-20167, 2000
PubMed
5) Willment JA, Gordon S, Brown GD : Characterization of the human β-glucan receptor and its alternatively spliced isoforms. J Biol Chem 276 : 43818-43823, 2001
 
6) Lipke PN, Ovalle R : Cell Wall Architecture in Yeast : New Structure and New Challenges. J Bacteriol 180 : 3735-3740, 1998
PubMed
7) Drickamer K : C-type lectin-like domain databases. Available HTTP : 'http://ctld.glycob.ox.ac.uk/ctld/mammals/humandata.html'. (updated : 28 June, 2002)
 
8) Taylor PR, Brown GD, Herre J, et al. : The role of SIGNR 1 and the β-glucan receptor (Dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J Immunol 172 : 1157-1162, 2004
 
9) Natarajan K, Dimasi N, Wang J, et al. : Structure and function of natural killer cell receptors : multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20 : 853-885, 2002
PubMed
10) Szabo T, Kadish JL, Czop JK : Biochemical properties of the ligand-binding 20-kDa subunit of the β-glucan receptors on human mononuclear phagocytes. J Biol Chem 270 : 2145-2151, 1995
 
11) Roubey RA, Ross GD, Merrill JT, et al. : Staurosporine inhibits neutrophil phagocytosis but not iC 3 b binding mediated by CR 3 (CD 11 b/CD 18) . J Immunol 146 : 3557-3562, 1991
PubMed
12) Rezzonico R, Chicheportiche R, Imbert V, et al. : Engagement of CD 11 band CD 11c β2 integrin by antibodies or soluble CD 23 induces IL-1β production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 95 : 3868-3877, 2000
 
13) Iwabuchi K, Nagaoka I : Lactosylceramideenriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 100 : 1454-1464, 2002
 
14) Masuzawa S, Yoshida M, Ishibashi K, et al. : Solubilized Candida cell wall β-glucan, CSBG, is an epitope of natural human antibody. Drug Devel Res 58 : 179-189, 2003
 
P.90 掲載の参考文献
1) Westphal O, Luderitz O, Galanos C, et al. : The story of bacterial endotoxin. Adv Immunopharmacol 3 : 13-34, 1986
 
2) Morrison DC, Ryan JL : Bacterial endotoxins and host immune responses. Adv Immunol 28 : 293-450, 1979
PubMed
3) Rietschel ET, Kirikae T, Schade FU, et al. : Bacterial endotoxin : molecular relationships of structure to activity and function. FASEB J 8 : 217-225, 1994
PubMed
4) Severinson E, Larsson EL : Lymphocyte responses to polyclonal T and B cell activators. In "Handbook of Experimental Immunology" 4th edition, ed Weir DM, Blackwell Scientific Publications, Oxford, 1986, Chapter 63, p 1-18
 
5) Kotani S, Takada H, Tsujimoto M, et al. : Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli Remutant. Infect Immun 49 : 225-237, 1985
PubMed
6) Zahringer U, Lindner B, Rietschel ET : Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohydr Chem Biochem 50 : 211-276, 1994
PubMed
7) Loppnow H, Brade H, Durrbaum 1, et al. : IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142 : 3229-3238, 1989
PubMed
8) Kovach NL, Yee E, Munford RS, et al. : Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J Exp Med 172 : 77-84, 1990
 
9) Ulmer AJ, Heine H, Feist W, et al. : Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures. Infect Immun 60 : 3309-3314, 1992
PubMed
10) Matsuura M, Kiso M, Hasegawa A : Activity of monosaccharide lipid A analogs in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide. Infect Immun 67 : 6286-6292, 1999
PubMed
11) Chuang TH, Ulevitch RJ : Identification of hTLR 10, a novel human Toll-like receptor preferentially expressed in immune cells. Biochem Biophys Acta 1518 : 157-161, 2001
 
12) Medzhitov R : Toll-like receptors and innate immunity. Nat Rev Immunol 1 : 135-145, 2001
PubMed
13) Vasselon T, Detmers PA : Toll receptors, a central element in innate immune responses. Infect Immun 70 : 1033-1041, 2002
PubMed
14) Shimazu R, Akashi S, Ogata H, et al. : MD-2, amolecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189 : 1777-1782, 1999
 
15) Chow JC, Young DW, Golenbock DT, et al. : Toll-like receptor 4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274 : 10689-10692, 1999
PubMed
16) Hoshino K, Takeuchi O, Kawai T, et al. : Toll-like receptor 4 (TLR 4) -deficient mice are hyporesponsive to lipopolysaccharide, evidence for TLR 4 as the Lps gene product. J Immunol 162 : 3749-3752, 1999
 
17) Qureshi ST, Lariviere L, Leveque G, et al. : Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr 4) . J Exp Med 189 : 615-625, 1999
 
18) Poltorak A, Ricciardi-Castagnoli P, Citterio S, et al. : Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 97 : 2163-2167, 2000
PubMed
19) Poltorak A, He X, Smirnova I, et al. : Defective LPS signaling in C 3 H/HeJ and C 57 BL/10 ScCr mice, mutations in 7lr4 gene. Science 282 : 2085-2088, 1998
 
20) Lien E, Means TK, Heine H, et al. : Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105 : 497-504, 2000
PubMed
21) Akashi S, Nagai Y, Ogata H, et al. : Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 13 : 1595-1599, 2001
PubMed
22) Funatogawa K, Matsuura M, Nakano M, et al. : Relationship of structure and biological activity of monosaccharide lipid A analogs to induction of nitric oxide production by murine macrophage RAW 264.7 cells. Infect Immun 66 : 5792-5798, 1998
 
23) Hirschfeld M, Weis JJ, Toshchakov V, et al. : Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69 : 1477-1482, 2001.
PubMed
24) Ogawa T, Asai Y, Hashimoto M, et al. : Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol 14 : 1325-1332, 2002
PubMed
25) Tamai R, Asai Y, Hashimoto M, et al. : Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4. Immunology 110 : 66-72, 2003
PubMed
P.100 掲載の参考文献
1) Nathan C : Inducible nitric oxide synthase : what difference does it make? J Clin Invest 100 : 2417-2423, 1997
 
2) MacMicking JD, Nathan C, Hom G, et al. : Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81 : 641-650, 1995
PubMed
3) Titheradge MA : Nitric oxide in septic shock. Biochim Biophys Acta 1411 : 437-455, 1999
PubMed
4) Lowenstein CJ, Alley EW, Raval P, et al. : Macrophage nitric oxide synthase gene : Two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc Natl Acad Sci USA 90 : 9730-9734, 1993
 
5) Murphy WJ, Muroi M, Zhang CX, et al. : Both basal and enhancerκB elements are required for full induction of the mouse inducible nitric oxide synthase gene. J Endotoxin Res 3 : 381-393, 1996
 
6) Xie QW, Whisnant R, Nathan C : Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferonγand bacterial lipopolysaccharide. J Exp Med 177 : 1779-1784, 1993
 
7) 土屋晃介, 光山正雄 : 細胞内寄生菌感染とNO. 医学のあゆみ 204 : 679-683, 2003
Medical*Online
8) Kawai T, Adachi O, Ogawa T, et al. : Unresponsiveness of MyD 88-deficient mice to endotoxin. Immunity 11 : 115-122, 1999
 
9) Medzhitov R, Preston-Hurlburt P, Kopp E, et al. : MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2 : 253-258, 1998
PubMed
10) Schilling D, Thomas K, Nixdorff K, et al. : Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP) /myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J Immunol 169 : 5874-5880, 2002
PubMed
11) Kawai T, Takeuchi O, Fujita T, et al. : Lipopolysaccharide stimulates the MyD 88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167 : 5887-5894, 2001
 
12) Toshchakov VB, Jones W, Zhang S, et al. : Differential Stat 1 a/b Phosphorylation Secondary to IFN-β Production Mediates the Distinct Pattern of Macrophage Gene Expression Observed in Response to TLR 4 and TLR 2 Agonists. Nature Immunol 3 : 392-398, 2002
 
13) Doyle S, Vaidya S, O'Connell R, et al. : IRF 3 mediates a TLR 3/TLR 4-specific antiviral gene program. Immunity 17 : 251-263 ; 1, 2002
 
14) Yoneyama M, Suhara W, Fukuhara Y, et al. : Direct triggering of the type I interferon system by virus infection : activation of a transcription factor complex containing IRF-3 and CBP/p 300. EMBO J 17 : 1087-1095, 1998
 
15) Martin E, Nathan C, Xie QW : Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180 : 977-984, 1994
PubMed
16) Morris KR, Lutz RD, Choi HS, et al. : Role of the NF-κB signaling pathway and κB cisregulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun 71 : 1442-1452, 2003
 
17) Bradley SG : Interactions between endotoxin and protein synthesis. In "Handbook of Endotoxin, Vol. 3 : Cellular Biology of Endotoxin" ed Berry LJ, Elsevier Science Publishers, Amsterdam, 1985, p 340
 
18) Oishi S, Hiraga K : Effect of polychlorinated biphenyl, dibenzofuran and dibenzo-p-dioxin on the susceptibility of male mice to endotoxin. J Environ Sci Health B 15 : 77-85, 1980
PubMed
19) Kuttner RE, Schumer W : Altered carbohydrate metabolism in endotoxin-tolerant rats after lead sensitization. Circ Shock 13 : 233-240, 1984
PubMed
20) Kleinert H, Schwarz PM, Forstermann U : Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384 : 1343-1364, 2003
PubMed
21) Kim YM, Lee BS, Yi KY, et al. : Upstream NF-κB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-γ plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 236 : 655-660, 1997
 
22) Xie QW, Kashiwabara Y, Nathan C : Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269 : 4705-4708, 1994
 
23) Gao J, Morrison DC, Parmely TJ et al. : An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J Biol Chem 272 : 1226-1230, 1997
 
24) 大柳善彦 : NO合成酵素とその作用機序. "NOと疾患-生体での一酸化窒素作用-" 医歯薬出版, 1994, p23-45
 
25) 小倉勧, 江角浩安 : NO産生とNO合成酵素 (NOS). "NOの生理作用と疾患" 谷口直之, 鈴木敬一郎編. 羊土社, 1999, p20-28
 
P.106 掲載の参考文献
1) Sibille Y, Reynolds HY : Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141 : 471-501, 1990
PubMed
2) 森田育男編 : "COX-2の理論と実証" メディカルビュー社, 2000
 
3) Ermert M, Kuttner D, Eisenhardt N, et al. : Cyclooxygenase-2-dependent and thromboxane-dependent vascular and bronchial responses are regulated via p 38 mitogenactivated protein kinase in control and endotoxin-primed rat lungs. Lab Invest 83 : 333-347, 2003
 
4) Loick HM, Theissen JL : Eicosanoids as mediators in ARDS. Anasthesiol Intensivmed Notfallmed Schmerzther 29 : 3-9, 1994
PubMed
5) The Acute Respiratory Distress Syndrome Network : Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342 : 1301, 2000
PubMed
6) Meduri GU, Chinn AJ, Leeper KV, et al. : Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 105 : 1516-1527, 1994
PubMed
7) TenHoor T, Mannino DM, Moss M : Risk factors for ARDS in the United States : analysis of the 1993 National Mortality Followback Study. Chest 119 : 1179-1184, 2001
PubMed
8) Iribarren C, Jacobs DR Jr, Sidney S, et al. : Cigarette smoking, alcohol consumption, and risk of ARDS : a 15-year cohort study in a managed care setting. Chest 117 : 163-168, 2000
 
9) Jurkovich GJ, Rivara FP, Gurney JG, et al. : The effect of acute alcohol intoxication and chronic alcohol abuse on outcome from trauma. JAMA 270 : 51-56, 1993
PubMed
10) Miller PR, Croce MA, Bee TK, et al. : ARDS after pulmonary contusion : accurate measurement of contusion volume identifies highrisk patients. J Trauma 51 : 223-230, 2001
PubMed
11) Moss M, Bucher B, Moore FA, et al. : The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA. 275 : 50-54, 1996
PubMed
12) Kolls JK, Xie J, Lei D, et al. : Differential effects of in vivo ethanol on LPS-induced TNF and nitric oxide production in the lung. Am J physiol 268 : L 991-998, 1995
 
13) Holguin F, Moss I, Brown LA, et al. : Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J Clin Invest 101 : 761-768, 1998
PubMed
14) Ware LB, Matthay MA : The acute respiratory distress syndrome. N Engl J Med 342 : 1334-1349, 2000
PubMed
15) Park WY, Goodman RB, Steinberg KP, et al. : Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 164 : 1896-1903, 2001
PubMed
16) Schuster DP, Stephenson AH, Holmberg S, et al. : Effect of eicosanoid inhibition on the development of pulmonary edema after acute lung injury. J Appl Physiol 80 : 915-923, 1996
PubMed
17) Concalves de Moraes VL, Boris Vargaftig B, Lefort J, et al. : Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. Br J pharmacol 117 : 1792-1796, 1996
 
18) Wakabayashi I, Yasui K, Negoro M : Diverse effects of ethanol on the pathway of inductble prostaglandin E 2 production in macrophages. Prostaglandins Other Lipid Mediat 67 : 61-74, 2002
PubMed
19) Pouliot M, Gilbert C, Borgeat P, et al. : Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J 12 : 1109-1123, 1998
PubMed
20) Nanji AA, Miao L, Thomas P, et al. : Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 112 : 943-951, 1997
PubMed
21) Luo J, Lindstrom CL, Donahue A, et al. : Differential effects of ethanol on the expression of cyclo-oxygenase in coltured astrocytes and neurons. J Neurochem 76 : 1354-1363, 2001
 
22) Monick MM, Robeff PK, Butler NS, et al. : Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA. J Biol Chem 277 : 32992-33000, 2002
PubMed
23) Spitzer JA, Zhang P, Bagby GJ, et al. : Sex differences in the modulation by ethanol of lung chemotaxis. Alcohol 28 : 95-102, 2002
PubMed
P.115 掲載の参考文献
1) Michel T, Reichhart J-M, Hoffmann JA, et al. : Drosophila Toll is activated by Grampositive bacteria through a circulating Peptidoglycan recognition protein. Nature 414 : 756-759, 2001
PubMed
2) Gottar M, Gobert V, Michel T, et al. : The Drosophila immune response against Gramnegative bacteria is mediated by a peptidoglycan recognition protein. Nature 416 : 640-644, 2002
PubMed
3) Takehana A, Katsuyama T, Yano T, et al. : Overexpression of a pattern-recognition receptor, peptidoglycan-recognition protein-LE, activates imd/relish-mediated antibacterial defense and the prophenoloxidase cascade in Drosophila larvae. Proc Natl Acad Sci USA 99 : 13705-13710, 2002
PubMed
4) Liu C, Xu Z, Gupta D, Dziarski R. : Peptidoglycan recognition proteins : a novel family of four human innate immunity pattern recognition molecules. J Biol Chem 276 : 34686-34694, 2001
PubMed
5) Wang Z-M, Li X, Cocklin RR, et al. : Human peptidoglycan recognition protein-L is an Nacetylmuramoyl-L-alanine amidase. J Biol Chem 278 : 49044-49052, 2003
 
6) Sashchenko LP, Dukhanina EA, Yashin DV, et al. : Peptidoglycan recognition protein Tag 7 forms a cytotoxic complex with heat shock protein 70 in solution and in lymphocytes. J Biol Chem 279 : 2117-2124, 2004
 
7) Takeda K, Kaisho T, Akira S : Toll-like receptors. Annu Rev Immunol 21 : 335-376, 2003
PubMed
8) Takada H, Kotani S : Immunopharmacological activities of synthetic muramylpeptides. In "Immunology of the Bacterial Cell Envelope" eds Stewart-Tull DES, Davies M, John Wiley & Sons, Chichester, 1985, p 119-152
 
9) Takada H, Kotani S : Muramyl dipeptide and derivatives. In "The Theory and Practical Application of Adjuvant" eds Stewart-Tull DES, Davies M, John Wiley & Sons, Chichester, 1995, p 171-202
 
10) Goto T, Aoki H : The immunomodulatory activities of acylpeptides. In "Immunostimulants : Now and Tomorrow" eds Azuma I and Jolles, Japan Sci. Soc. Press, 1987, p 99-108
 
11) Yoshimura A, Lien E, Ingalls RR, et al. : Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163 : 1-5, 1999
PubMed
12) Vidal VF, Castoran N, Riendeau CJ, et al. : Macrophage stimulation with murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signalregulated kinases 1 and 2, C/EBPβ and STAT 1 : role of CD 14 and Toll-like receptors 2 and 4. Eur J Immunol 31 : 1962-1971, 2001
 
13) Yang S, Tamai R, Akashi S, et al. : Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 69 : 2045-2053, 2001
PubMed
14) Takada H, Yokoyama S, Yang S : Enhancement of endotoxin activity by muramyldipeptide. J Endotoxin Res 8 : 337-342, 2002
PubMed
15) Inohara N, Ogura Y, Fontalba A, et al. : Host recognition of bacterial muramyl dipeptide mediated through NOD 2. J Biol Chem 278 : 5509-5512, 2003
 
16) Girardin SE, Boneca IG, Viala J, et al. : Nod 2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278 : 8869-8872, 2003
 
17) Girardin SE, Boneca IG, Carneiro LAM, et al. : Nod l detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300 : 1584-1587, 2003
 
18) Chamaillard M, Hashimoto M, Horie Y, et al. : An essential role for NOD 1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4 : 702-707, 2003
PubMed
19) Uehara A, Sugawara S, Tamai R, et al. : Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharides, lipoteichoic acids and peptidoglycans in the presence of soluble CD 14. Med Microbiol Immunol 189 : 185-192, 2001
 
20) Bertin J, Nir W-J, Fischer CM, et al. : Human CARD 4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J Biol Chem 274 : 12955-12958, 1999
 
21) Inohara N, Koseki T, del Peso L, et al. : Nod 1, an apaf-1-like activator of caspase-9 and nuclear factor-κB. J Biol Chem 274 : 14560-14567, 1999
 
22) Inohara N, Koseki T, Lin J, et al. : An induced proximity model for NF-κB activation in the Nod 1/RICK and RIP signaling pathways. J Biol Chem 275 : 27823-27831, 2000
 
P.121 掲載の参考文献
1) 中野昌康, 小玉正智編 : エンドトキシン 新しい治療・診断・検査. 講談社サイエンティフィック, 1995
 
2) Beeson PB : Tolerance to bacterial pyrogens. Proc Soc Exp Biol Med 61 : 248-250, 1946
PubMed
3) Lehner M D, Morath S, Michelsen K S, et al. : Induction of cross-Tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 166 : 5161-5167, 2001
PubMed
4) Remi R N, FuYan L, Tejdip S, et al. : Endotoxin induces a dose-dependent myocardial cross-tolerance to ischemia-reperfusion injury. Crit Care Med 28 : 1439-1444, 2000
 
5) 比企直樹, 三村芳和, 上西紀夫, 他 : 外科領域におけるエンドトキシントレランスの応用. "エンドトキシン研究 4" 日本エンドトキシン研究会編. 医学図書出版, 2001, p177-183
 
6) Kojima J, Mimura Y, Hiki N, et al. : Sympathetic nervous system is related to induction of endotoxin tolerance via beta-adrenergic receptor. J Endotoxin Res 6 : 174, 2000
 
7) 畑尾史彦, 比企直樹, 上西紀夫, 他 : synthetic LPS receptor agonistを用いたEndotoxin Toleranceの獲得. "エンドトキシン研究 5" 日本エンドトキシン研究会編. 医学図書出版, 2002, p166-172
 
8) Salkowski C A, Detore G, Franks A, et al. : Pulmonary and hepatic gene expression following cecal ligation and puncture : monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect Immun 66 : 3569-3578, 1998
PubMed
9) Jean-Marc Cavaillon : The nonspecific nature of endotoxin tolerance. Trends in microbiology 3 : 320-324, 1995
 
10) West MA, Heagy W : Endotoxin tolerance : A review. Crit Care Med 30 : S64-73, 2002
 
11) Heagy W, Hansen C, Nieman K, et al. : impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock 14 : 271-276, 2000
PubMed
12) Akira S : Mini review Toll-like receptor signaling. J Biol Chem 278 : 38105-38108, 2003
 
13) Fujihara M, Muroi M, Tanamoto K : Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide : roles of the receptor complex. Pharmacol and Therapentics 100 : 171-194, 2003
PubMed
14) Wang JH, Doyle M, Manning BJ, et al. : Cutting edge : bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J Immunol 170 : 14-18, 2003
PubMed
15) Yeo S J, Yoon J G, Hong S C, et al. : CpG DNA induces self and cross-hyporesponsiveness of RAW 264.7 cells in response to CpG DNA and lipopolysaccharide : alterations in IL-1 receptor-associated kinase expression. J Immunol 170 : 1052-1061, 2003
 
16) Kobayashi K, Hernandez L D, Galan J E et al. : IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110 : 191-202, 2002
 
17) Nakagawa R, Naka T, Tsutsui H, et al. : SOCS-1 participates in negative regulation of LPS responces. Immunity 17 : 677-687, 2002
 
P.128 掲載の参考文献
1) 三宅健介 : エンドトキシン (LPS) 認識機構. "エンドトキシン研究 6" 日本エンドトキシン研究会編. 医学図書出版, 2003, p23-30
 
2) Shimazu R, Akashi S, Ogata H, et al. : MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-1ike receptor 4. J Exp Med 189 : 1777-1782, 1999
 
3) Visintin A, Mazzoni A, Spitzer J A, et al. : Secreted MD-2 is a large polymeric protein that efnciently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 98 : 12156-12161, 2001
PubMed
4) Akashi S, Shimazu R, Ogata H, et al. : Cutting Edge : Cell surface expression and lipopolisaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164 : 3471-3475, 2000
 
5) Nagai Y, Akashi S, Nagafuku M, et al. : Essential role of MD-2 in LPS responsiveness and TLR 4 distribution. Nat Immunol 3 : 667-672, 2002
 
6) Akashi S, Saitoh S-i, Wakabayashi Y, et al. : Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2 : Higher Affinity than that with MD-2 or CD 14. J Exp Med 198 : 1035-1042, 2003
 
7) Kawasaki K, Nogawa H, and Nishijima M : Identification of mouse MD-2 residues important for forming the cell surface TLR 4-MD-2 complex recognized by anti-TLR 4-MD-2 antibodies, and for conferring LPS and Taxol responsiveness on mouse TLR 4 by alaninescanning mutagenesis. J Immunol 170 : 413-420, 2003
PubMed
8) Wells J A : Systematic mutational analyses of protein-protein interfaces. Methods Enzymol 202 : 390-411, 1991
PubMed
9) Kawasaki K, Akashi S, Shimazu R, et al. : Mouse Toll-like Receptor 4・MD-2 Complex Mediates Lipopolysaccharide-mimetic Signal Transduction by Taxol. J Biol Chem 275 : 2251-2254, 2000
 
10) Kawasaki K, Gomi K, Nishijima M : Gin-22 of mouse MD-2 is essential for speciesspecific lipopolysaccharide mimetic action of Taxol. J Immunol 166 : 11-14, 2001
 
P.131 掲載の参考文献
1) Fridkin SK, Jarvis WR : Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9 : 499-511, 1996
PubMed
2) LaRocco MT, Burgert SJ : Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 10 : 277-297, 1997
 
3) Patel R, Paya CV : Infections in solid-organ transplant recipients. Clin Microbiol Rev 10 : 86-124, 1997
PubMed
4) Walsh TJ, Gonzalez C, Roilides E, et al. : Fungemia in children infected with the human immunodeficiency virus : new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin Infect Dis 20 : 900-905, 1995
PubMed
5) Ohno N, Uchiyama M, Tsuzuki A, et al. : Solubilization of yeast cell-wall beta- (1→3) -D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr Res 316 : 161-172, 1999
 
6) Tokunaka K, Ohno N, Adachi Y, et al. : Immunopharmacological and immunotoxicological activities of a water-soluble β- (1→3) -glucan, CSBG from Candida spp. Int J Immunopharmac 22 : 383-394, 2000
 
7) Raylander R, Fogelmark B, McWilliam A, et al. : (1→3) -β-D-glucan may contribute to pollen sensitivity. Clin Exp Immunol 115 : 383-384, 1999
 
P.136 掲載の参考文献
1) Helicobacter pylori感染の診断と治療のガイドライン. "学会誌選定論文集 (2001-2003)" ヘリコバクター学会編, 診断と治療社, 2003, p191-197
 
2) Harvey HA, Porat N, Campbell CA, et al. : Gonococcal lipopolysaccharide is a ligand for the asialoglycoprotein receptor on human sperm. Mol Microbiol 36 : 1059-1070, 2000
PubMed
3) Yuki N : Pathogenesis of Guillan-Barre and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Jpn J Infect Dis 52 : 99-105, 1999
 
4) Hirota K, Osawa R, Nemoto K, et al. : Highly expressed human sialyl Lewis antigen on cell surface of Streptococcus gallolyticus. Lancet 347 : 760, 1996
PubMed
5) Okano M, Satoskar AR, Nishizaki K, et al. : Induction of Th 2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma masoni egg antigens. J Immunol 163 : 6712-6717, 1999
 
6) 天野憲一, 横田伸一 : Helicobacter Pyloriリポ多糖の構造と血清学的特異性. 日本細菌学雑誌 56 : 421-433, 2001
Medical*Online
7) Amano K, Hayashi S, Kubota T, et al. : Reactivities of Lewis antigen monoclonal anti-bodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan. Clin Diagn Lab Immunol 4 : 540-544, 1997
 
8) Yokota S, Amano K, Hayashi S, et al. : Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumors of patients with gastric cancer. Infect Immun 65 : 3509-3512, 1997
PubMed
9) Yokota S, Amano K, Shibata Y, et al. : Two distinct antigenic types of the polysaccharide chains of Helicobacter pylori lipopolysaccharides characterized by reactivity with sera from humans with natural infection. Infect Immun 68 : 151-159, 2000
 
10) Yokota S, Amano K, Chiba S, et al. : Structures, biological activities and antigenic properties of Helicobacter pylori lipopolysaccharide. Recent Res Devel Microbiol 7 : 251-267, 2003
 
11) Appelmelk BJ, Monteiro MA, Martin SL, et al. : Why Helicobacter pylori has Lewis antigens. Trends Microbiol 8 : 565-570, 2000
PubMed
12) Ogawa T, Suda Y, Kashihara W, et al. : Immunological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Poryphyromonas gingivalis lipid A. Vaccine 15 : 1598-1605, 1997
 
13) Piotrowski J, Piotrowski E, Skrodzka D, et al. : Induction of acute gastritis and epitherial apoptosis by 」Uelicobacter pylori lipopolysaccharide. Scand J Gastroenterol 32 : 203-211, 1997
 
14) Kawahara T, Teshima S, Oka A, et al. : Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gstric pit cells. Infect Immun 69 : 4382-4389, 2001
 
15) Appelmelk BJ, Martin SL, Monteiro MA, et al. : Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the length of poly (C) tracts in α3-fucosyltransferase genes. Infect Immun 67 : 5361-5366, 1999
 
P.144 掲載の参考文献
1) 小野聡, 玉熊正悦, 望月英隆, 他 : 外科的感染症の重篤化因子とその対策に関する臨床的実験的検討. 日本外科学会雑誌 92 : 1300-1303, 1991
 
2) Wysocka M, Kubin M, Vieira LQ, et al. : Interleukin-12 is required for interferongamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 25 : 672-676, 1995
PubMed
3) Ozmen L, Pericin M, Hakimi J, et al. : Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med 180 : 907-915, 1994
PubMed
4) Ogasawara K, Takeda K, Hashimoto W, et al. : Involvement of NK 1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. J Immunol 160 : 3522-3527, 1998
PubMed
5) 佐藤賢吾, 木下学, 羽生仁子, 他 : 加齢による全身性シュワルツマン反応の増強とCD8+ CD122+ αβT細胞 (intermediate CD8細胞) の関与について. "エンドトキシン研究 6" 日本エンドトキシン研究会編. 医学図書出版, 2003, p112-118
 
6) Ohkawa T, Seki S, Dobashi H, et al. : Systematic characterization of Human CD8+ T cells with natural Killer sell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology 103 : 281-290, 2001
 
7) Takayama E, Seki S, Ohkawa T, et al. : Mouse CD8+ CD122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production. J Immunol 164 : 5652-5658, 2000
PubMed
P.149 掲載の参考文献
1) Hofmann J A, Kafatos F C, Janeway C A, et al. : Phylogenetic persectives in innate immunity. Science 284 : 1313-1318, 1999
 
2) Kawamata T, Imaizumi H, Yoshida M, et al. : Polymixin B-immobilized fiber improves hyperdynamic state in MRSA septic patients. Intensive Care Med 23 : 130-131, 1997
 
3) Takeuchi O, Hoshino K, Kawai T, et al. : Differential roles of TLR 2 and TLR 4 in recognition of gram-negative and gram-positive bacterial cell components. Immunity 11 : 443-451, 1999
PubMed
4) Wang Y, Liu Y, Sarker K P, et al. : Polymixin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 470 : 151-155, 2000
 
5) 江副英理, 今泉均, 佐藤守仁, 他 : ポリミキシン固定化カラムを用いた直接血液灌流 (PMX-DHP) による敗血症性ショックの菌種別昇圧効果の機序. "エンドトキシン研究 4-世界をリードするわが国の研究-" 日本エンドトキシン研究会 窪田達也, 他編. 医学図書出版, 2001, p201-206
 
6) 今泉均, 升田好樹, 佐藤守仁, 他 : グラム陽性菌による敗血症性ショックに対するPMXDHP治療とanandamide吸着による臨床効果. "エンドトキシン研究 4-世界をリードするわが国の研究-" 日本エンドトキシン研究会 窪田達也, 他編. 医学図書出版, 2001, p 207-216
 
7) 今泉均, 佐藤守仁, 升田好樹, 他 : グラム陽性菌による敗血症性ショックに対するPMXDHP治療とその有効性の機序-内因性cannabinoidsの関与-. ICUとCCU 25別冊号 : S39-41, 2001
 
P.154 掲載の参考文献
1) 図説 我が国の慢性透析療法の現況 (2002年12月31日現在) 日本透析医学会統計調査委員会編. 日本透析医学会, 2003, p3-4
 
2) 武本佳昭, 土田健司, 仲谷達也 : 血液透析濾過の適応病態. 大阪透析研究会会誌 20 : 233-236, 2002
Medical*Online
3) Gejyo F, Homma N, Arakawa M : Longterm complications of dialysis : Pathogenic factors with special reference to amyloidosis. Kidney Int 41 : S 78-S 82, 1993
 
4) Tsuchida K, Takemoto Y, Yamagami S, et al. : Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods. Nephron 75 : 438-443, 1997
PubMed
5) Lonnemann G : Chronic infiammation in hemodialysis : The role of contaminated dialysate. Blood Purif 18 : 214-223, 2000
 
6) Urena P, Herbelin A, Zingraff J, et al. : Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 7 : 16-28, 1992.
PubMed
7) Miyata T, Inagi R, Kurokawa K : Diagnosis, pathogenesis, and treatment of dialysisrelated amyloidosis. Miner Electrolyte Metab 25 : 114-117, 1999
PubMed
8) Zimmermann J, Herrlinger S, Pruy A, et al. : Inflammation enhances cardiovascular risk and mortality in hemodialysis. Kidney Int 55 : 648-658, 1999
PubMed
9) Goicoechea M, Martin J, Sequera P, et al. : Role of cytokine in the response to erythropoietin in hemodialysis patients. Kidney Int 54 : 1337-1343, 1998
PubMed
10) 佐藤隆, 福成健一, 姜景智, 他 : 透析液清浄化がもたらすもの. 腎と透析別冊HDF療法 '03 55 : 47-51, 2003
 
11) Baz M, Durand C, Ragon A, et al. : Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 4 : 681-685, 1991
PubMed
12) 政金生人, 矢吹清一, 佐藤幸一, 他 : 透析液清浄化でなにが変わったか. 腎と透析別冊ハイパフォーマンスメンブレン '99 47 : 24-27, 1999
 
13) SchiHI H, Land SM, Bergner A, et al. : Ultrapure dialysate reduces dose of recombinant human erythropoietin. Nephron 83 : 278-279, 1999
 
14) Polenakovic M, Sikole A : Is erythropoietin a survival factor for red blood cell ? J Am Soc Nephrol 7 : 1178-1182, 1996
PubMed
15) Tarng DC, Huang TP, Chen TW, et al. : Erythropoietin hyporesponseiveness : From iron deficiency to iron overload. Kidney Int 55 : S107-S118, 1999
 
16) Burger T, Karatson A, Tatai Z, et al. : Iron turnover in patients with chronic uraemia treated with hemodialysis. Acta Med Acad Sci Hung 39 : 193-200, 1982
PubMed
17) Najean Y, Moynot A, Deschryver F, et al. : Kinetics of erythropoiesis in dialysis patients receiving recombinant erythropoietin treatment. Nephrol Dial Transplant 4 : 350-355, 1989
PubMed
18) Jiao Y, Okumiya T, Saibara T, et al. : An enzymatic assay for erythrocyte creatine as an index of the erythrocyte life time. Clin Biochem 31 : 59-65, 1998
PubMed
19) Takemoto Y, Okumiya T, Tsuchida K, et al. : Erythrocyte creatine as an index of the erythrocyte life span and erythropoiesis. Nephron 86 : 513-414, 2000
PubMed
20) 山上征二 : 透析安全基準策定報告. 透析会誌 28 : 1487-1493, 1995
 
21) Freedman MH, Saunder EF, Cattran DC, et al. : Ribonuclease inhibition of erythropoiesis in anemia of uremia. Am J Kidney Dis 2 : 530-533, 1983
 
P.162 掲載の参考文献
1) Neugebauer EA, Holadag JW : "Handbook of Mediator in Septic Shock" CRC Press. Raton, FL, 1993
 
2) Stoclet JC, Schott CA, Schneider F, et al. : Induction by endotoxin of nitric oxide production in vascular smooth muscle cells. In "Shock Sepsis Organ Faillure-Nitric Oxide" eds Schlag G, Redl H, Springer, Berlin, 1995, p102-117
 
3) Kumar A, Parillo JE : Myocardial depression in septic shock : role of nitric oxide and other mediators. In "Shock Sepsis and Organ Faillure-Nitric Oxide," eds Schlag G, Redl H, Springer, Berlin, 1995, p 322-341
 
4) Shah AM, Henderson AH : Effect of endocardial damage on myocardial contraction. In "Myocardial Response to Acute Injury, eds Parrott, Macmillan, Basingstoke, 1992, p 153-169
 
5) Schmidt H H H W, Wamer TD, Murad F : Double-edged role of endogenous nitric oxide. Lancet 339 : 986, 1992
 
6) Petros A, Bennett D, Vallance P : Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338 : 1557-1558, 1991
PubMed
7) Suga H, Nakagawa T, Soga Y, et al. : In "6th World Congress on Trauma, Shock, Inflammation and Sepsis, ed Faist E, Medimond, 2004, p157-161
 
8) Kilbourne RG, Szabo C, Traber DL : Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock : Lessons learned from experimental and clinical studies. Shock 7 : 235-264, 1997
 
9) Szabo C, Southan BJ, Thiemermann C : Beneficial effects and improved survival in rodent model of septic shock with S-methyliothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91 : 12472-12476, 1994
 
10) Bellomo R, Kellum JA, Wisniewski SR, et al. : Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am JRespir Crit Care Med 159 : 1186-1192, 1999
PubMed
11) Treggiari MM, Romand JA, Burgener D, et al. : Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. Crit Care Med 30 : 1334-1339, 2002
 
12) Zhang H, Smail N, Cabral A, et aL : Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock. Am J Respir Crit Care Med 155 : 1965-1971, 1997
PubMed
13) Vallet BN, Lund SC, Curtis D, et al. : Gut and muscle tissue Pco2 in endotoxemic dog during shock and resuscitation. J Appl Physiol 76 : 793-800, 1994
 
14) Wang P, Z F Ba, A Ayala, et al. : Hepatocellular dysfunction persist during early sepsis despite increased volume of crystalloid resuscitation. J Trauma 32 : 389-397, 1992
 
15) Marshall J C : The gut-liver axis in multiple organ failure. In "Mediators of Sepsis" eds M Lamy, L G Thijs, Springer Verlag, Berlin, 1992, p220-237
 
16) Malay MB, Ashton RCJ, Landry DW, et al. : Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47 : 699-705, 1999
 
17) Landry DW, Levin HR, Gallant EM, et al. : Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 : 1122-1125, 1997
 
18) Morales D, Madigan J, Cullinane S : Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100 : 226-229, 1999
PubMed
19) Martin W, Dunser MD, Andreas J, et al. : The Effects of Vasopressin on Systemic Hemodynamics in Catecholamine-Resistant Septic and Postcardiotomy Shock : A Retrospective Analysis. Anesth Analg 93 : 7-13, 2001
 
20) Evora PR, Pearson PJ, Schaff HV : Arginine vasopressin induces endothelium-dependent vasodilation of the pulmonary artery : VIreceptor-mediated production of nitric oxide. Chest 103 : 1241-1245, 1993
 
P.167 掲載の参考文献
1) Chen CC, Wang JK : p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264. 7 macrophages. Mol Pharmacol 55 : 481-488, 1999
 
2) Chen C, Chen YH, Lin WW : Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J 774 macrophages. Immunology 97 : 124-129, 1999
 
3) Kizaki T, Suzuki K, Hitomi Y, et al. : Negative regulation of LPS-stimulated expression of inducible nitric oxide synthase by AP-1 in macrophage cell line J 774 A. 1. Biochem Biophys Res Commun 289 : 1031-1038, 2001
 
P.172 掲載の参考文献
1) Riedemann NC, Guo RF, Ward PA : The enigma of sepsis. J Clin Invest 112 : 460-467, 2003
PubMed
2) Guarner F, Malagelada JR : Gut flora in health and disease. Lancet 361 : 512-519, 2003
PubMed
3) Alverdy JC, Laughlin RS, Wu L : Influence of the critically ill state on host-pathogen interactions within the intestine : gut-derived sepsis redefined. Crit Care Med 31 : 598-607, 2003
PubMed
4) Fink MP : Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med 19 : 627-641, 1991
 
5) Rotstein OD : Antioxidant therapy in critical illness. Crit Care Med 32 : 610-611, 2004
PubMed
6) Keyse SM, Tyrrell RM : Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 86 : 99-103, 1989
PubMed
7) Morse D, Choi AM : Heme oxygenase-1 : the "emerging molecule" has arrived. Am J Respir Cell Mol Biol 27 : 8-16, 2002
PubMed
8) Shimizu H, Takahashi T, Suzuki T, et al. : Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 28 : 809-817, 2000
PubMed
9) Odaka Y, Takahashi T, Yamasaki A, et al. : Prevention of halothane-induced hepatotoxicity by hemin pretreatment : protective role of heme oxygenase-1 induction. Biochem Pharmacol 59 : 871-880, 2000
PubMed
10) Suzuki T, Takahashi T, Yamasaki A, et al. : Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific delta-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome. Biochem Pharmacol 60 : 275-283, 2000
 
11) Fujii H, Takahashi T, Nakahira K, et al. : Protective role of heme oxygenase-1 in the intestinal tissue injury in an experimental model of sepsis. Crit Care Med 31 : 893-902, 2003
 
12) Otani K, Shimizu S, Chijiiwa K, et al. : Administration of bacterial lipopolysaccharide to rats induces heme oxygenase-1 and formation of antioxidant bilirubin in the intestinal mucosa. Dig Dis Sci 45 : 2313-2319, 2000
PubMed
13) Valaes T : Bilirubin toxicity : the problem was solved a generation ago. Pediatrics 89 : 819-821, 1992
PubMed
14) Wang WP, Guo X, Koo MW, et al. : Protective role of heme oxygenase-10n trinitrobenzene sulfonic acid-induced colitis in rats. Am J physiol Gastrointest Liver Physiol 281 : G586-594, 2001
 
15) Otterbein LE, Choi AM : Heme oxygenase : colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279 : L1029-1037, 2000
PubMed
16) Toda N, Takahashi T, Mizobuchi S, et al. : Tin chloride pretreatment prevents renal injury in rats with ischemic acute renal failure. Crit Care Med 30 : 1512-1522, 2002
PubMed
17) Tamaki T, Konoeda Y, Yasuhara M, et al. : Glutamine-induced heme oxygenase-1 protects intestines and hearts from warm ischemic injury. Transplant Proc 31 : 1018-1019, 1999
PubMed
18) Wischmeyer PE, Kahana M, Wolfson R, et al. : Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 90 : 2403-2410, 2001
 
19) Garlick PJ : Assessment of the safety of glutamine and other amino acids. J Nutr 131 : 2556S-2561 S, 2001
 
20) Coeffier M, Le Pessot F, Leplingard A, et al. : Acute enteral glutamine infusion enhances heme oxygenase-1 expression in human duodenal mucosa. J Nutr 132 : 2570-2573, 2002
PubMed
21) Adams JK, Tepperman BL : Colonic production and expression of IL-4, IL-6, and IL-10 in neonatal suckling rats after LPS challenge. Am J Physiol Gastrointest Liver Physiol 280 : G755-762, 2001
PubMed
22) Young VR, Ajami AM : Glutamine : the emperor or his clothes? JNutr 131 : 2449S-2459S ; discussion 2486S-2447S, 2001
PubMed
23) Wilmore DW, Shabert JK : Role of glutamine in immunologic responses. Nutrition 14 : 618-626, 1998
PubMed
24) Novak F, Heyland DK, Avenell A, et al. : Glutamine supplementation in serious illness : a systematic review of the evidence. Crit Care Med 30 : 2022-2029, 2002
PubMed
25) Wischmeyer PE : Glutamine and heat shock protein expression. Nutrition 18 : 225-228, 2002
PubMed
26) Mates JM, Perez-Gomez C, Nunez de Castro I, et al. : Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol 34 : 439-458, 2002
PubMed
27) Herbert V, Shaw S, Jayatilleke E, et al. : Most free-radical injury is iron-related : it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12 : 289-303, 1994
PubMed
28) Baranano DE, Rao M, Ferris CD, et al. : Biliverdin reductase : a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 99 : 16093-16098, 2002
 
29) Otterbein LE, Bach FH, Alam J, et al. : Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 : 422-428, 2000
PubMed
30) Brouard S, Otterbein LE, Anrather J, et al. : Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192 : 1015-1026, 2000
PubMed
P.180 掲載の参考文献
1) Cohen J : The detection and interpretation of endotoxemia. Intensive Care Med 26 : 51-56, 2000
 
2) Venet C, Zeni F, Viallon A, et al. : Endotoxemia in patients with severe sepsis or shock. Intensive Care Med 26 : 538-544, 2000
 
3) Fessler JF, Bottoms GD, Coppoc GL, et al. : Plasma endotoxin concentrations in experimental and clinical equine subjects. Equine Vet J Suppl 7 : 24-28, 1989
PubMed
4) Yokota M, Kambayashi J, Tanaka T : A simple turbidimetric time assay of the endotoxin in plasma. J Biochem Biophys Methods 18 : 97-104, 1989
 
5) 田村弘志, 有本やよい, 田中重則, 他 : カイネティック自動アッセイによる新しい血中エンドトキシンおよび (1→3) -β-D-グルカン定量法. 医学のあゆみ 166 : 811-812, 1993
Medical*Online
6) Obayashi T : Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate : Comparison with conventional procedures and clinical applications. J Lab Clin Med 104 : 321-330, 1984
PubMed
7) Obayashi T, Tamura H, Tanaka S, et al. : A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzyme and its clinical applications. Clin Clim Acta 149 : 55-65, 1985
 
8) Inada K, Endo S, Takahashi K, et al. : Establishment of a new perchloric acid treatment method to allow determination of the total endotoxin content in human plasma by the Limulus test and clinical application. Microbiol Immunol 35 : 303-314, 1991
PubMed
9) Oishi H, Takaoka A, Hatayama Y, et al. : Automated Limulus amebocyte lysate (LAL) test for endotoxin analysis using a new Toxinometer ET-201. J Parenter Sci Technol 39 : 194-200, 1985
PubMed
10) ACCP/SCMCC Consensus Conference Committee : Definition for sepsis and organ failure and guideline for the use of innovative therapies in sepsis. Chest 1992 101 : 1644-1655, Crit Care Med 20 : 864-874, 1992
 
11) Shoji H, Tani T, Hanasawa K, et al. : Extracorporeal endotoxin removal by Polymyxin B immobilized fiber cartridge : designing and antiendotoxin efficacy in the clinical application. Therapeutic Apheresis 2 : 3-12, 1997
 
12) 稲田捷也, 遠藤重厚 : リムルス試薬を用いた血中エンドトキシンおよびβ-グルカン定量におけるカイネティクス法での特異反応と非特異反応の判別. 医学と薬学 42 : 885-897, 1999
 
P.188 掲載の参考文献
1) Emancipator K, Csajo G, Elin RJ : In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun 60 : 596-601, 1992
PubMed
2) 八重樫泰法, 稲田捷也, 佐藤信博, 他 : 血漿高感度エンドトキシン測定について. エンドトキシン血症救命治療研究会誌 7 : 25-28, 2003
 
3) Tobias PS, Soldau K, Ulevich R : Isolation of a lipopolysaccharide-binding acute phase reactanr from rabir serum. J Exp Med 164 : 777-793, 1986
 
4) Wright SD, Ramos AR, Tobias PS : CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 : 1431-1433, 1990
 
5) Yaegashi Y, Inada K, Sato N, et al. : Soluble CD14 subtype as a new diagnostic maker of sepsis. Shock 21 : 108, 2004
 
6) Vincent JL, Moreno R, Takala J : The SOFA (sepsis-related organ failue assessment) score to describe organ dysfunction/faiIure. Intensive Care Med 22 : 707-710, 1996
 
P.193 掲載の参考文献
1) Natanson C, Hoffmann W D, Suffredini A, et al. : Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120 : 771-783, 1994
 
2) Zeni F, Freeman BD, Natanson C : Antiinflammatory therapies to treat sepsis and septic shock. Crit Care Med 25 : 1095-1100, 1997
 
3) Meisner M : PCT-procalcitonin. A new and innovative parameter in diagnosis of infections B. R. A. H. M. S. Diagnostica, Berlin, 1996, p14-60
 
4) Gendrel D, Bohuon C : Procalcitonin, a marker of bacterial infections. Infection 25 : 133-134, 1997
PubMed
5) Assicot M, Gendrel D, Carsin H, et al. : High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341 : 515-518, 1993
PubMed
6) Rau B, Steinback G, Baumgart K, et al. : The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 26 : 159-164, 2000
 
7) Monneret G, Labaune JM, Isaac C, et al. : Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr 86 : 209-212, 1997
 
8) F K Brunkhorst, K Wegscheider, Z F Forycki, et al. : Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 26 : 148-152, 2000
 
9) J Schroder, K H Staubach, P Zabel, et al. : Procalcitonin as a marker of severity in septic shock. Langenbeck's Arch Surg 384 : 33-38, 1999
 
10) Rangel-Frausto MS, Pittet D, Costigan M, et al. : The natural history of the systemic inflammatory response syndrome (SIRS) a prospective study. JAMA 273 : 117-123, 1995
PubMed
11) Goris RJA, te Boekhorst TPA, Nuytinet JKS, et al. : Generalized autodestructive inflammation. Arch Surg 120 : 1109-1115, 1995
 
12) 谷内仁, 池田寿昭, 池田一美, 他 : 敗血症性多臓器不全-障害臓器数と病態-各種メデイエーターとの関連. エンドトキシン血症救命治療研究会誌 7 : 146-151, 2003
 
13) Zygmunt P M, Petersson J, Andersson D A, et al. : Vanilloid receptors on sensory nerves mediates the vasodilator action of anandamide. Nature 400 : 452-457, 1999
PubMed
P.207 掲載の参考文献
1) Tsutsumi R, Ichinohe N, Shimooki O, et al. : Homologous and heterologous antibody responses to lipopolysaccharide after enterohemorrhagic Escherichia coli infection. Microbiol Immunol 48 : 27-38, 2004
PubMed
2) Makino K, Yokoyama K, Kubota Y, et al. : Complete nucleotide sequence of the prophage VT 2-Sakai carrying the verotoxin 2 genes of the enterohemorrhagic Escherichia coli O 157 : H7 derived from the Sakaioutbreak. Genes Genet Syst 74 : 227-239, 1999
 
3) Yokoyama K, Makino K, Kubota Y, et al. : Complete nucleotide sequence of the prophage VT 1-Sakai carrying the Shiga toxin 1 genes of the enterohernorrhagic Escherichia coli O157 : H7 strain derived from the Sakai outbreak. Gene 258 : 127-139, 2000
 
4) Sato T, Shimizu T, Watarai M, et al. : Genome analysis of a novel Shiga toxin 1 (Stx 1) -converting phage which is closely related to Stx 2-converting Phages but not to other Stx 1-converting Phages. J Bacteriol 185 : 3966-3971, 2000
PubMed
5) Strauch E, Lurz R, Beutin L : Characterization of a Shiga toxin-encoding temperate bacteriophage of Shigella sonnei. Infect Immun 69 : 7588-7595, 2001
PubMed
6) Yaron S, Kolling GL, Simon L, et al. : Vesicle-mediated transfer of virulence genes from Escherichia coli O157 : H7 to other enteric bacteria. Appl Environ Microbiol 66 : 4414-4420, 2000
PubMed
7) Chart H, Scotland SM, Rowe B. J : Serum antibodies to Escherichia coli serotype O 157 : H7 in patients with hemolytic uremic syndrome. Clin Microbiol 27 : 285-290, 1989
 
8) 林英生, 倉園久生 : 腸管出血性大腸菌 (EHEC) の分離・同定法. 日本細菌学会誌 52 : 747-799, 1997
 
9) 竹田多恵 : 腸管出血性大腸菌感染症の血清学的診断法. 臨床と微生物 23 : 821-826, 1996
Medical*Online
10) 甲斐明美, 山田澄夫, 伊藤武, 他 : EHEC-O抗原に対する抗体価測定によるEHEC感染症の血清学的診断法とその有用性. 日本臨床 55 : 680-685, 1997
Medical*Online
11) Morooka T, Matano H, Umeda A, et al. : Indirect hemagglutination assay for antibodies to Escherichia coli lipopolysaccharides O157, O111 and O26 in patients with hemolytic uremic syndrome. Acta Paediatr Jpn 37 : 469-473, 1995
PubMed
12) 菅原由人, 雑賀威, 長谷川美幸, 他 : ELISA法による腸管出血性大腸菌O157LPS IgM IgG抗体測定の基礎および臨床的検討. 感染症学雑誌 73 : 503-508, 1999
 
13) 足立枝里子, 吉野健一, 竹田多恵 : 腸管出血性大腸菌O157の成人, 小児および成人保菌者の抗O157LPS抗体価の変動. 感染症学雑誌 73 : 772-777, 1999
 
14) Chart H, Evans J, Chalmers RM, et al. : Escherichia coli O157 serology : false-positive EHSA results caused by human antibodies binding to bovine serum albumin. Lett Appl Microbiol 27 : 76-78, 1998
 
15) Peterfi Z, Kocsis B : Comparison of blocking agents for an ELISA for LPS. J Immunoassay 21 : 341-354, 2000
PubMed
16) Kishore K, Rattan A, Bagga A, et al. : Serum antibodies to verotoxin-producing Escherichia coli (VTEC) strains in patients with haemolytic uraemic syndrome. J Med Microbiol 37 : 364-367, 1992
PubMed
17) Laegreid W, Hoffman M, Keen J, et al. : Development of a blocking enzyme-linked immunosorbent assay for detection of serum antibodies to O157 antigen of Escherichia coli. Clin Diagn Lab Immunol 5 : 242-246, 1998
PubMed
18) Bacterial polysaccharide Gene Database 1998 Online Microbioplogy Department, University of Sydney, Australia. http://www.microbio.usyd.edu.au/BPGD/default.htm
 
19) Goldwater PN, Bettelheim KA : New perspectives on the role of Escherichin coli O 157 : H7 and other enterohaemorrhagic E. coli serotypes in human disease. J Med Microbiol 47 : 1039-1045, 1998
 
20) Goldwater PN, Bettelheim KA : Escherichia coli 'O' group serology of a haemolytic uraemic syndrome (HUS) epidemic. Scand J Infect Dis 32 : 385-394, 2000
PubMed
21) Kulkarni H, Goldwater PN, Martin A, et al. : Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients. Comp Immunol Microbiol Infect Dis 25 : 249-268, 2002
PubMed
22) Palermo MS, Alves Rosa MF, Van Rooijen N, et al. : Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Clin Exp Immunol 116 : 462-467, 1999
 
23) Ikeda M, Ito S, Honda M : Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol 19 : 485-489, 2004
 
24) Paton AW, Voss E, Manning PA, et al. : Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells. Microb Pathog. 24 : 57-63, 1998
PubMed
25) 木村晋亮, 小崎明子, 佐々木富子, 他 : 散発性下痢患者および健常者から分離された糞便由来大腸菌O抗原血清型の比較と地域差. 感染症学雑誌 73 : 53-61, 1999
 
P.215 掲載の参考文献
1) Seibert FB : Introduction to the symposium on bacterial pyrogens. Trans N Y Acad Sci Feb 14 : 157-159, 1952
 
2) Westphal O : Bacterial endotoxins. Int. Arch. Allergy Appl Immunol 49 : 1-43, 1975
PubMed
3) Levin J, Bang FB : The role of endotoxin in the extracellular coagulation of limulus blood. Bull Johns Hopkins Hosp 115 : 265-274, 1964
PubMed
4) Daoust DR, Orlowski SJ, McMahon G, et al. : Limulus amebocyte lysate test as a method for detection of endotoxins and endotoxin-like materials. Bull Parenter Drug Assoc 30 : 13-20, 1976
PubMed
5) US Pharmacopeia 10 th, Bacterial Endotoxin Test, 1980
 
6) European Pharmacopoeia, 2rd edn. Supplement, 1983
 
7) Japanease Pharmacopoeia, 11 th edn., 1986
 
8) Ministry of Health and Welfare, Japanese Government, Minumum Riquirements for Biological Products 1993
 
9) Bangham DR : The dilemma of quantitation in the test for pyrogens in : pyrogens and fever, Ciba Found Symp : 207-214, 1971
PubMed
10) Weary ME, Wallin RF : The rabbit pyrogen test. Lab Anim Sci Oct 23 : 677-681, 1973
PubMed
11) Ditter B, Becker KP, Urbaschek R, et al. : Quantitative endotoxin determination. Automated kinetic Limulus amebocyte lysate microtiter test with measurement of samplerelated interferences. Arzneimittel-Forschung 33 : 681-687, 1983
PubMed
12) Schleef RR, Kenney DM, Shepro D : Effect of sodium chloride on limulus amebocyte lysate. Inhibition of endotoxin activation of procoagulase. Thromb Haemost 41 : 329-336, 1979
PubMed
13) Cooper JF, Pearson SM : Detection of endotoxin in biological products by the limulus test. Dev Biol Stand 34 : 7-13, 1977
PubMed
14) Yamamoto A, Ochiai M, Kataoka M, et al. : Development of a highly sensitive in vitro assay method for biological activity of endotoxin contamination in biological products. Biologicals 30 : 85-92, 2002
PubMed
15) Wachtel RE, Tsuji K : Comparison of limulus amebocyte lysates and correlation with the United States Pharmacopeial pyrogen test. Appl Environ Microbiol 33 : 1265-1269, 1977
PubMed
16) Ronneberger HJ : Comparison of the pyrogen tests in rabbits and with limulus lysate. Dev Biol Stand 34 : 27-36, 1977
PubMed
17) Poxton IR, Edmond DM : Biological activity of Bacteroides lipopolysaccharide-reappraisal. Clin Infect Dis Jun 20 Suppl 2 : S149-153, 1995
 
18) Luchi M, Morriso DC : Comparable endotoxic properties of lipopolysaccharides are manifest in diverse clinical isolates of gram-negative bacteria. Infect Immun Apr 68 : 1899-1904, 2000
 
19) Ohchiai M, Kataoka M, Toyoizumi H, et al. : A quantitative in vitro assay method for detecting biological activity of endotoxin using prostagrandin E2 induction in rabbit peripheral blood. Microbiol Immunol 47 : 585-590, 2003
 
20) Ochiai M, Kataoka M, Toyoizumi H, et al. : A quantitative in vitro assay for detecting biological activity of endotoxin using rabbit peripheral blood. Jpn J Infect Dis 54 : 131-136, 2001
PubMed
21) Terrell TG, Green JD : Comparative pathology of recombinant muraine interferongamma in mice and recombinant human interferon-gamma in cynomolgus monkeys. Int Rev Exp Pathol 34 Pt B : 73-101, 1993
 
22) Pool EJ, Johaar G, James S, et al. : The detection of pyrogens in blood products using as ex vivo whole blood culture assay. J Immunoassay 19 : 95-111, 1998
 
23) Fennrich S, Fischer M, Hartung T, et al. : Detection of endotoxins and other pyrogens using human whole blood. Dev Biol Stand 101 : 131-139, 1999
PubMed
24) Yamamoto A, Ochiai M, Kamachi K, et al. : A cell line assay system for predicting the response of human blood to endotoxin. Jap J Infect Dis 56 : 93-100, 2003
 
25) Yamamoto A, Ochiai M, Kamachi K, et al. : Augmenting effect of antibiotics on endotoxin activity may cause a safety problem. Mlcrobiol Immunol 48 : 97-102, 2004
 
26) Endotoxin-like reactions associated with intravenous gentamicin-California, 1998. MMWR Morb Mortal Wkly Rep 47 : 877-880, 1998
PubMed

書評

最近チェックした商品履歴

Loading...